What You Ought to Know:
– CVS Health Clinical Trial Services and late clinical-stage mobile therapeutics firm ProKidney Corp. right this moment introduced a collaboration to enroll sufferers with kind 2 diabetes and power kidney illness into the proact 1 (REGEN-006) Part 3 medical trial of REACT®.
ProKidney’s lead product candidate, REACT® (REnal Autologous Cell Remedy), is a first-of-its-kind, patented, autologous mobile remedy with the potential to not solely gradual and stabilize the development of CKD, however in some instances probably drive significant enchancment in kidney perform.
